Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019028450) METHOD FOR PRODUCING THERAPEUTIC EXOSOMES FROM NANOELECTROPORATION AND OTHER NON-ENDOCYTIC CELL TRANSFECTION
Note: Text based on automatic Optical Character Recognition processes. Please use the PDF version for legal matters

CLAIMS

What is claimed is:

Claim 1. A method of producing a large number of therapeutic extracellular vesicles (EVs) containg high copies of functional nucleic acids and other biomolecules

comprising the steps of::

laying donor cells on a surface of a chip, the surface having a three-dimensional (3D) nanochannel electroporation (NEP) biochip formed thereon;

adding various plasmids, other transfection vectors and their combinations to a buffer on the chip;

applying a pulsulatic electric field across the cells laid on top of the chip surface and plasmids/vectors buffer solution below the chip surface, resulting in strongly stimulating the cells and delivering plasmids/vectors into cells non-endocytically; and collecting EVs secreted by the transfected cells.

Claim 2. The method of claim 1 , wherein the diameter of nanochannels is between 50-900 nm.

Claim 3. The method of claim 1 or 2, wherein the plasmids and vectors transcribe mRNA, microRNA, shRNA, and other RNAs, and lead to translation of proteins and other biomolecules in the transfected cells.

Claim 4. The method of any one of the preceding claims, wherein EVs secreted by the transfected cells contain the transcribed mRNA, microRNA, shRNA, and other RNAs, and the translated proteins and other biomolecules.

Claim 5. The method of any one of the preceding claims, wherein means to increase the expression of heat shock proteins and other proteins that promote vesicle formation and exocytosis in the transfected cells are added to the system, wherein the means includes a thermal shock treatment of the cells, or addition of heat shock proteins in cell culture.

Claim 6. The method of any one of the preceding claims, wherein means to increase the expression of proteins that promote exosome formation in the transfected cells are added to the system, wherein the means includes co-transfection of CD63, CD9 and other DNA plasmid.

Claim 7. The method of any one of the preceding claims, wherein multiple DNA plasmids and other vectors are delivered to the transfected cells sequentially to promote co-localization of RNA/protein targets and EV secretion.

Claim 8. The method of any one of the preceding claims, wherein exogenous biomolecules such as DNA plasmids, other transfection vectors, RNAs, proteins/peptides, small molecule drugs are encapsulated within vesicles in cells and secreted out as therapeutic EVs by sequential transfection of donor cells by NEP.

Claim 9. The method of claim 8, wherein, in addition to NEP, other cell transfection methods that provide strong stimulation to donor cells to facilite EV secrection and non-endocytic plasmid/vector delivery for fast RNA transcription and protein translation produce therapeutic EVs with similar efficacy.

Claim 10. The method of claim 9, wherein the other cell transfection methods include, gene gun, and micro- or nanoinjection.

Claim 11. The method of any one of claims 8 to 10, wherein the plasmids and/or other vectors are tethered on nano- or micron-sized gold or other solid particles, and those particles are injected into donor cells under a pneumatuc force using a gene gun to cause strong cell stimulation and non-endocytic plasmis/vector delivery.

Claim 12. The method of any one of claims 8 to 1 1 , wherein the the plasmids and/or other vectors are tethered on a nano- or micron-sized tip array, and donor cells are pultruded by those tips to cause strong cell stimulation and non-endocytic plasmis/vector delivery into donor cells.

Claim 13. A device for producing a large number of therapeutic extracellular vesicles (EVs) containg high copies of functional nucleic acids and other biomolecules, comprising:

a chip having a three-dimensional (3D) nanochannel electroporation (NEP) biochip and a buffer for receiving formed thereon, the buffer adapted for receiving plasmids and other transfection vectors.

Claim 14. Cells transfected by the method of any one of claims 1 to 12.